企業プロフィール
Cardiff Oncology 株価・ニュース・カタリスト
- ティッカー:
- CRDF
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.90 USD (-6.10%)
終値
最終更新: 2026年8月17日
103M USD
時価総額
株価変動の要因
As of Aug 17, 2026, CRDF closed down 6.10% at $0.9043. No new same-company headline was identified in the current news window.
企業概要
事業概要
Cardiff Oncology is an oncology company focused on precision cancer therapy and cell-cycle biology. Its development strategy is centered on targeted treatment combinations for solid tumors.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Cardiff sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, pathway validation, and the ability to create a differentiated oncology franchise.
バイオ業界での位置付け
Cardiff is a small-cap oncology catalyst name whose stock moves on early clinical readouts.
今後のカタリスト
- Cardiff Oncology’s catalysts are onvansertib and the KRAS-driven oncology program, especially any new combination or clinical data that keep the story alive. The company remains highly dependent on proof of differentiation.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。